British Journal of Cancer - Table of Contents alert Volume 119 Issue 4

If you are unable to see the message below, click here to view.

Advertisement Researchoncology.com Explore the latest science, research, and clinical trials in hematology and oncology.   TABLE OF CONTENTS Volume 119, Issue 4 In this issue Review Article Article Brief Communication Article Correspondence Also new AOP   Advertisement ========================================== Register for the latest nature.com webcast========================================== Distinct Metabolic Profiling of Invading PANC-1 Pancreatic Cancer Cells During this webcast Dr. Mayumi Fujita of the National Institutes for Quantum and Radiological Science and Technology in Japan will address the method of real-time imaging of invading cells using the IncuCyte Live-Cell Analysis System, and describe how this model is useful for many studies.  Register for FREE today  Sponsored by IncuCyte Review Article Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? Mareike K. Thompson, Philip Poortmans, Anthony J. Chalmers, Corinne Faivre-Finn, Emma Hall et al. British Journal of Cancer 2018 119 :389 - 407; July 31, 2018; 10.1038/s41416-018-0201-z   Abstract | Full Text Article Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer Naomi B. Boekel, Judy N. Jacobse, Michael Schaapveld, Maartje J. Hooning, Jourik A. Gietema et al. British Journal of Cancer 2018 119 :408 - 418; August 01, 2018; 10.1038/s41416-018-0159-x   Abstract | Full Text Serial mutational tracking in surgically resected locally advanced colorectal cancer with neoadjuvant chemotherapy Keishi Sugimachi, Shotaro Sakimura, Shotaro Kuramitsu, Hidenari Hirata, Atsushi Niida et al. British Journal of Cancer 2018 119 :419 - 423; August 03, 2018; 10.1038/s41416-018-0208-5   Abstract | Full Text Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study Simon Pernot, Olivier Dubreuil, Thomas Aparicio, Karine Le Malicot, David Tougeron et al. British Journal of Cancer 2018 119 :424 - 428; June 06, 2018; 10.1038/s41416-018-0133-7   Abstract | Full Text Isolated limb perfusion for unresectable extremity cutaneous squamous cell carcinoma; an effective limb saving strategy Eva A. Huis in ’t Veld, Dirk J. Grünhagen, Jan P. Deroose, Tamar E. C. Nijsten, Michel W. J. M. Wouters et al. British Journal of Cancer 2018 119 :429 - 434; July 02, 2018; 10.1038/s41416-018-0149-z   Abstract | Full Text Tumour-stroma ratio and prognosis in gastric adenocarcinoma Niko Kemi, Maarit Eskuri, Anni Herva, Joni Leppänen, Heikki Huhta et al. British Journal of Cancer 2018 119 :435 - 439; July 30, 2018; 10.1038/s41416-018-0202-y   Abstract | Full Text STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer Abdi Ghaffari, Nichole Peterson, Kasra Khalaj, Natasha Vitkin, Andrew Robinson et al. British Journal of Cancer 2018 119 :440 - 449; July 26, 2018; 10.1038/s41416-018-0188-5   Abstract | Full Text Angiopoietin-like protein 3 blocks nuclear import of FAK and contributes to sorafenib response Yi Bao, Fu Yang, Bing Liu, Tangliang Zhao, Zhipeng Xu et al. British Journal of Cancer 2018 119 :450 - 461; July 23, 2018; 10.1038/s41416-018-0189-4   Abstract | Full Text Transcription factors WT1 and p53 combined: a prognostic biomarker in ovarian cancer Julia H. Carter, James A. Deddens, Gretchen Mueller, Thomas G. Lewis, Mariah K. Dooley et al. British Journal of Cancer 2018 119 :462 - 470; July 30, 2018; 10.1038/s41416-018-0191-x   Abstract | Full Text The value of using the faecal immunochemical test in general practice on patients presenting with non-alarm symptoms of colorectal cancer Jakob Søgaard Juul, Nete Hornung, Berit Andersen, Søren Laurberg, Frede Olesen et al. British Journal of Cancer 2018 119 :471 - 479; August 01, 2018; 10.1038/s41416-018-0178-7   Abstract | Full Text L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile Felix KF Kommoss, Anthony N. Karnezis, Friedrich Kommoss, Aline Talhouk, Florin-Andrei Taran et al. British Journal of Cancer 2018 119 :480 - 486; July 27, 2018; 10.1038/s41416-018-0187-6   Abstract | Full Text Brief Communication Detection of circulating tumour cell clusters in human glioblastoma Ilona Krol, Francesc Castro-Giner, Martina Maurer, Sofia Gkountela, Barbara Maria Szczerba et al. British Journal of Cancer 2018 119 :487 - 491; August 01, 2018; 10.1038/s41416-018-0186-7   Abstract | Full Text Article Exosome-packaged miR-1246 contributes to bystander DNA damage by targeting LIG4 Li-Jun Mo, Man Song, Qiao-Hua Huang, Hua Guan, Xiao-Dan Liu et al. British Journal of Cancer 2018 119 :492 - 502; July 24, 2018; 10.1038/s41416-018-0192-9   Abstract | Full Text Impact of the second reader on screening outcome at blinded double reading of digital screening mammograms Angela M. P. Coolen, Adri C. Voogd, Luc J. Strobbe, Marieke W. J. Louwman, Vivianne C. G. Tjan-Heijnen et al. British Journal of Cancer 2018 119 :503 - 507; July 24, 2018; 10.1038/s41416-018-0195-6   Abstract | Full Text A machine learning approach to radiogenomics of breast cancer: a study of 922 subjects and 529 DCE-MRI features Ashirbani Saha, Michael R. Harowicz, Lars J. Grimm, Connie E. Kim, Sujata V. Ghate et al. British Journal of Cancer 2018 119 :508 - 516; July 23, 2018; 10.1038/s41416-018-0185-8   Abstract | Full Text Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison Yvette H. M. Claassen, Nina C. A. Vermeer, Lene H. Iversen, Elizabeth van Eycken, Marianne G. Guren et al. British Journal of Cancer 2018 119 :517 - 522; July 30, 2018; 10.1038/s41416-018-0215-6   Abstract | Full Text Correspondence Comment on ‘Anthropometric measurements and survival after prostate cancer diagnosis’ Luigino Dal Maso, Antonella Zucchetto, Carmen Stocco, Diego Serraino & Jerry Polesel British Journal of Cancer 2018 119 :523 - 524; July 31, 2018; 10.1038/s41416-018-0161-3   Abstract | Full Text Reply to ‘Comment on ‘Anthropometric measurements and survival after prostate cancer diagnosis” Megan S. Farris, Kerry S. Courneya, Karen A. Kopciuk, S. Elizabeth McGregor & Christine M. Friedenreich British Journal of Cancer 2018 119 :525 - 526; July 31, 2018; 10.1038/s41416-018-0213-8   Abstract | Full Text Advertisement Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.